4//SEC Filing
Nicosia Matthew 4
Accession 0001683168-20-002002
CIK 0001081938other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 11:22 AM ET
Size
7.9 KB
Accession
0001683168-20-002002
Insider Transaction Report
Form 4
Nicosia Matthew
Director10% Owner
Transactions
- Other
Series A Preferred
2018-04-20$1.00/sh−10,000$10,000→ 26,000 totalExercise: $0.00From: 2018-06-17→ Common Stock (12,500,000 underlying) - Sale
Series A Preferred
2019-06-17$1.00/sh−4,000$4,000→ 16,000 totalExercise: $0.00From: 2018-04-20→ Common Stock (5,000,000 underlying)
Footnotes (2)
- [F1]The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time.
- [F2]The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated.
Documents
Issuer
CANNAPHARMARX, INC.
CIK 0001081938
Entity typeother
Related Parties
1- filerCIK 0001452672
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 11:22 AM ET
- Size
- 7.9 KB